Chemotherapy and targeted therapies have significantly improved the prognosis of
oncology patients. However, these antineoplastic treatments may also induce adverse …

Nanotechnology has emerged as a promising approach for the targeted delivery of
therapeutic agents while improving their efficacy and safety. As a result, nanomaterial …

With the improvement in cancer prognosis due to advances in antitumor therapeutic
protocols and new targeted and immunotherapies, we are witnessing a growing increase in …

Advancements in cancer treatments have improved survival rates but have also led to
increased cardiotoxicities, which can cause adverse cardiovascular events or worsen pre …

5-fluorouracil (5-FU) is a potent anticancer agent, but its significant tissue toxicity associated
with increased oxidative stress and inflammation may limit its clinical use. Chlorogenic acid …

Background Fluoropyrimidines (FPs) are an essential part of the majority of systemic
regimens in the treatment of metastatic colorectal cancer (CRC). The use of the oral FP S-1 …

Considering the pandemic of both cardiovascular diseases and oncological diseases, there
is an increasing need for the use of chemotherapy, which through various …

Elevated resting heart rate is frequently observed in cancer patients, and is associated with
increased mortality. Although specific chemotherapeutic agents can induce cardiotoxicity …

With the continuous refinement of therapeutic measures, the survival rate of tumor patients
has been improving year by year, while cardiovascular complications related to cancer …

Aims Fluoropyrimidine chemotherapy is important for treatment of many solid tumours but is
associated with cardiotoxicity. The relationship of fluoropyrimidine‐associated cardiotoxicity …